Results 241 to 250 of about 167,880 (309)
The current obesity drug landscape, dominated by GLP‐1 receptor agonists and emerging multi‐agonist therapies, has reinforced that long‐term weight loss is achieved in large part through central mechanisms that suppress appetite and reshape energy balance.
Ines Martinez‐Corral +3 more
wiley +1 more source
Metabolic remodelling in anthracycline cardiotoxicity: mechanisms and therapeutic insights
Cardiac metabolic remodelling in anthracycline‐induced cardiomyopathy and metabolically oriented cardioprotective strategies. Schematic representation of substrate utilization, mitochondrial bioenergetic function and metabolic flexibility in the healthy heart, in anthracycline‐induced cardiomyopathy and under potential cardioprotective interventions ...
Giulia Guerra +5 more
wiley +1 more source
Exploring the therapeutic applications of metformin in articular cartilage repair: mechanistic insights and translational perspectives. [PDF]
Jin P +11 more
europepmc +1 more source
Severe Metformin Intoxication Resulting in Extreme Lactic Acidosis. [PDF]
Kozárová M +4 more
europepmc +1 more source
Acquired BRAFi Resistance Increases Melanoma Cell Sensitivity to Metabolic Targeting with Metformin. [PDF]
Arbe MF +3 more
europepmc +1 more source
Metformin potentiates arsenic disulfide in diffuse large B-cell lymphoma: modulation of BAX/BCL-2 apoptotic pathway and hedgehog pathway. [PDF]
Zhang J +5 more
europepmc +1 more source

